Yushi Katsuyama

Dr. Yushi Katsuyama


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YKYushi Katsuyama
Yushi Katsuyama
NTNorihisa Taira
Norihisa Taira
MYMasato Yoshioka
Masato Yoshioka
YOYuri Okano
Yuri Okano
HMHitoshi Masaki
Hitoshi Masaki

1 June 2016 in Journal of Dermatological Science
Verified
Journal Article
Closed access
YKYushi Katsuyama
Yushi Katsuyama
TTTatsuya Tsuboi
Tatsuya Tsuboi
NTNorihisa Taira
Norihisa Taira
MYMasato Yoshioka
Masato Yoshioka
HMHitoshi Masaki
Hitoshi Masaki

28 June 2016 in International Journal of Cosmetic Science
Verified
Journal Article
Closed access
PDF file
YKYushi Katsuyama
Yushi Katsuyama
NTNorihisa Taira
Norihisa Taira
TTTatsuya Tsuboi
Tatsuya Tsuboi
MYMasato Yoshioka
Masato Yoshioka
HMHitoshi Masaki
Hitoshi Masaki
OMOsamu Muraoka
Osamu Muraoka

1 May 2018 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
YKYushi Katsuyama
Yushi Katsuyama
NTNorihisa Taira
Norihisa Taira
MYMasato Yoshioka
Masato Yoshioka
YOYuri Okano
Yuri Okano
HMHitoshi Masaki
Hitoshi Masaki
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

7 November 2017 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
NTNorihisa Taira
Norihisa Taira
YKYushi Katsuyama
Yushi Katsuyama
MYMasato Yoshioka
Masato Yoshioka
YOYuri Okano
Yuri Okano
HMHitoshi Masaki
Hitoshi Masaki

Verified
Journal Article
Open access
PDF file
TNTaira Norihisa
Taira Norihisa
YKYushi Katsuyama
Yushi Katsuyama
MYMasato Yoshioka
Masato Yoshioka
OMOsamu Muraoka
Osamu Muraoka
Toshio MorikawaToshio Morikawa
Toshio Morikawa
L-Ascorbic acid has multifunctional benefits on skin aesthetics, including inhibition of melanin production, and is widely used in cosmetics. It, however, has low stability and poor skin penetration. We hypothesize that alkylglyceryl-l-ascorbic acid derivatives, highly stable vitamin C–alkylglycerol conjugates, would have similar anti-melanogenic activity with better stability and penetration. We test 28 alkylglyceryl-l-ascorbic acid derivatives (1–28) on theophylline-stimulated B16 melanoma 4A5 cells to determine if they inhibit melanogenesis and establish any structure–function relationships. Although not the most potent inhibitors, 3-O-(2,3-dihydroxypropyl)-2-O-hexyl-l-ascorbic acid (6, IC50 = 81.4 µM) and 2-O-(2,3-dihydroxypropyl)-3-O-hexyl-l-ascorbic acid (20, IC50 = 117 µM) are deemed the best candidate derivatives based on their inhibitory activities and low toxicities. These derivatives are also found to be more stable than l-ascorbic acid and to have favorable characteristics for skin penetration. The following structural requirements for inhibitory activity of alkylglyceryl-l-ascorbic acid derivatives are also determined: (i) alkylation of glyceryl-l-ascorbic acid is essential for inhibitory activity; (ii) the 3-O-alkyl-derivatives (2–14) exhibit stronger inhibitory activity than the corresponding 2-O-alkyl-derivatives (16–28); and (iii) derivatives with longer alkyl chains have stronger inhibitory activities. Mechanistically, our studies suggest that l-ascorbic acid derivatives exert their effects by suppressing the mRNA expression of tyrosinase and tyrosine-related protein-1.